Joint Formulary & PAD

Venlafaxine - Generalised Anxiety Disorder (GAD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Modified release capsules
  • Modified release tablets
Associated Icons :
SPC
Restrictions / Comments :
Important

In Primary Care, OptimiseRx will be used to recommend the most cost-effective formulation at the point of prescribing. 

 

Status 2

Green
Formulations :
  • Tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :
Important

Only the modified-release formulations hold a license for anxiety disorders. The use of ordinary tablets is off-label.

PAD Profile

ChemicalSubstance :
Venlafaxine
Indication :
Generalised Anxiety Disorder (GAD)
Group Name :
Keywords :
Brand Names Include :
Efexor XL, Sunveniz XL, Venladex XL, Venaxx, Depefex, Venlalic, Vensir XL, ViePax XL, Vencarm XL,
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
2

Committee Recommendations (1)

15 Aug 18 - Not Set

The Mood Hive and associated local depression and anxiety treatment guidelines have been removed from PAD. Updated guidelines and resources for treating and managing depression in adults are being developed by Surrey & Borders Partnership. For current advice, in line with NICE guidance, please see the Clinical Knowledge Summaries.

Other Indications

Below are listed other indications that Venlafaxine is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Generalised Anxiety Disorder (GAD).